Mechanistically, the AhR-dependent promotion of several pro-oncogenic signaling pathways (e.g., JAK2-Src interaction) is independent of the transcriptional activities of the AhR, suggesting the involvement of non-canonical AhR signaling in the promotion of lung cancer progression [67]. The gene discussed is AHR; the disease is lung carcinoma.